Table 2.
Name | Accession number | Sequence (5′‐3′) |
---|---|---|
β‐Actin | NM_001101 | F: GGGTACCGATGGATGATGATATCGCCGC |
R: GGGATCCCGCTAGAAGCATTTGCGGTGGAC | ||
Cav1 | AB451284 | F: GCTCGAGATGTCTGGGGGCAAATACGTAG |
R: GGAATTCGTATTTCTTTCTGCAAGTTGATGCG | ||
Clc | NM_001834 | F: GGGTACCGATGGCTGATGACTTTGGCTTC |
R: GGGATCCCGCTAGCGGGACAGTGGCGT | ||
Dyn2 | BC054501 | F: GCTCGAGATGGGCAACCGCGGGATG |
R: GGAATTCGGTCGAGCAGGGATGGCTCG | ||
K44A | F: AGCGCCGGCGCGAGCTCGGTGCTGGAGAAC | |
R: CACCGAGCTCGCGCCGGCGCTCTGGCCGCC |
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.